Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of IQVIA Holdings Inc.. A complete text table follows the diagram.
The life-sciences data company expects $8.9B of its contracted R&D Solutions backlog to convert to revenue within 12 months
Swipe to explore
Backlog is not GAAP revenue and differs from remaining performance obligations. IQVIA states that backlog includes contracts under which customers may have unilateral cancellation rights; timing and realization can therefore change.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| R&D Solutions contracted backlog | 1 | $34.2 | Up from $34.0B at year-end |
| Expected within 12 months | 2 | $8.9 | 26% of contracted backlog |
| Longer-dated contracted work | 2 | $25.3 | 74% arithmetic remainder |
| From | To | Value |
|---|---|---|
| R&D Solutions contracted backlog | Expected within 12 months | $8.9 |
| R&D Solutions contracted backlog | Longer-dated contracted work | $25.3 |